J&J seeks regulator nod for vax trials in 12-17 age group in India
The single-shot vaccine of J&J is the second Covid-19 vaccine which has already been approved for the Emergency Use Authorisation (EUA).
The single-shot vaccine of J&J is the second Covid-19 vaccine which has already been approved for the Emergency Use Authorisation (EUA).
The five vaccines granted Emergency Use Authorisation in India are Serum Institute's Covishield, Bharat Biotech's Covaxin, Russia's Sputnik V, Moderna, and now Johnson & Johnson (J&J).
